PapersFlow Research Brief
Drug-Induced Ocular Toxicity
Research Guide
What is Drug-Induced Ocular Toxicity?
Drug-Induced Ocular Toxicity refers to retinal disorders, retinopathy, maculopathy, and optic neuropathy caused by medications including chloroquine, hydroxychloroquine, tamoxifen, and ethambutol.
The field encompasses 25,661 published works on drug-induced ocular conditions such as retinopathy and optic neuropathy linked to specific medications. Screening guidelines and imaging methods like multifocal electroretinography and optical coherence tomography (OCT) are central to detection and management. Papers address implications for rheumatology care alongside cardiomyopathy risks from these drugs.
Topic Hierarchy
Research Sub-Topics
Hydroxychloroquine Retinopathy
This sub-topic details toxic maculopathy patterns, bull's eye lesions, and progression in long-term users for rheumatologic conditions. Researchers correlate dosage, duration, and genetic factors with retinal damage.
Chloroquine-Induced Retinal Toxicity
Studies investigate chloroquine's effects on retinal pigment epithelium, photoreceptor loss, and vascular changes in malaria and autoimmune treatments. Comparative analyses with hydroxychloroquine highlight differential risks.
Tamoxifen Maculopathy
Research covers tamoxifen's cystoid macular edema, intraretinal crystals, and correlation with cumulative dose in breast cancer survivors. Multimodal imaging tracks subclinical changes and reversibility.
Ethambutol Optic Neuropathy
This sub-topic examines dose-dependent optic nerve damage, color vision deficits, and recovery patterns in tuberculosis therapy. Electrophysiological tests and risk stratification aid clinical management.
Screening Guidelines for Drug Toxicity
Scholars develop and validate protocols using OCT, visual fields, and mfERG for early detection of subclinical toxicity. Evidence-based revisions incorporate AI and risk calculators for high-risk drugs.
Why It Matters
Drug-Induced Ocular Toxicity affects patients on long-term therapies for conditions like systemic lupus erythematosus and malaria, where antimalarials such as hydroxychloroquine cause retinopathy detectable via OCT screening. "Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)" by Marmor et al. (2016) provides updated protocols that enable early intervention, preventing vision loss in rheumatology patients. "Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review" by Ruiz‐Irastorza et al. (2008) documents side effects including retinopathy, guiding safer dosing in over 960-cited analyses. During COVID-19, trials like "Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19" by Geleris et al. (2020, 1714 citations) evaluated hydroxychloroquine safety, highlighting retinopathy risks in acute settings.
Reading Guide
Where to Start
"Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)" by Marmor et al. (2016), as it provides foundational clinical guidelines on detection using OCT and electroretinography, essential for understanding practical management.
Key Papers Explained
"Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)" by Marmor et al. (2016, 1114 citations) establishes screening standards referenced in later works. "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology" by Schrezenmeier and Dörner (2020, 1434 citations) explains toxicity pathways building on those guidelines. "Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review" by Ruiz‐Irastorza et al. (2008, 960 citations) quantifies risks in lupus, connecting preclinical mechanisms to clinical outcomes.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent COVID-19 trials like "Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19" by Geleris et al. (2020, 1714 citations) and "Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19" by Horby (2020, 1271 citations) assess short-term ocular safety, shifting focus to acute toxicity risks amid expanded use.
Papers at a Glance
Frequently Asked Questions
What screening methods are recommended for chloroquine and hydroxychloroquine retinopathy?
"Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)" by Marmor et al. (2016) outlines protocols using optical coherence tomography (OCT) and multifocal electroretinography for early detection. Baseline exams and annual screening for high-risk patients prevent irreversible vision loss. These guidelines apply to rheumatology patients on long-term therapy.
How does hydroxychloroquine cause ocular toxicity?
Hydroxychloroquine induces retinopathy and maculopathy through mechanisms affecting retinal pigment epithelium, as discussed in papers on its rheumatology applications. "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology" by Schrezenmeier and Dörner (2020) details toxicity pathways. Screening per Marmor et al. (2016) detects changes early.
What are the side effects of antimalarials in lupus patients?
"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review" by Ruiz‐Irastorza et al. (2008) identifies retinopathy and maculopathy as key ocular toxicities. These occur with prolonged use but are manageable via dose adjustments and OCT monitoring. Efficacy outweighs risks in most cases with adherence to screening.
Which drugs commonly cause optic neuropathy?
Ethambutol and chloroquine are associated with optic neuropathy in drug-induced ocular toxicity studies. The field covers these alongside hydroxychloroquine retinopathy. Screening guidelines from Marmor et al. (2016) aid in distinguishing toxic effects from other neuropathies.
What role does OCT play in detecting drug-induced retinopathy?
Optical coherence tomography (OCT) visualizes retinal layer changes in hydroxychloroquine and chloroquine toxicity. It is recommended in "Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)" by Marmor et al. (2016) for quantitative assessment. Multifocal electroretinography complements OCT for functional evaluation.
Open Research Questions
- ? What are the precise cellular mechanisms of chloroquine-induced retinal pigment epithelium damage?
- ? How can imaging biomarkers predict irreversible hydroxychloroquine maculopathy progression?
- ? Which genetic factors influence susceptibility to ethambutol optic neuropathy?
- ? What optimal screening intervals minimize vision loss in long-term tamoxifen users?
- ? How do cardiomyopathy and retinopathy risks interact in hydroxychloroquine-treated rheumatology patients?
Recent Trends
COVID-19 trials drove a surge in hydroxychloroquine studies, with "Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19" by Geleris et al. garnering 1714 citations and "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology" by Schrezenmeier and Dörner (2020) reaching 1434 citations.
2020These emphasize retinopathy monitoring during widespread administration.
The field totals 25,661 works, sustaining focus on screening per Marmor et al. .
2016Research Drug-Induced Ocular Toxicity with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Drug-Induced Ocular Toxicity with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers